VICTORY CAPITAL MANAGEMENT INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,124,915
-32.4%
24,460
-15.5%
0.00%
-50.0%
Q2 2023$1,662,952
+1.4%
28,936
-33.8%
0.00%0.0%
Q1 2023$1,640,175
+57.8%
43,738
+17.9%
0.00%
+100.0%
Q4 2022$1,039,318
+1.5%
37,092
+1.8%
0.00%0.0%
Q3 2022$1,024,000
-34.2%
36,427
-18.6%
0.00%
-50.0%
Q2 2022$1,557,000
-30.0%
44,750
-28.6%
0.00%0.0%
Q1 2022$2,224,000
+33.3%
62,699
-12.4%
0.00%0.0%
Q4 2021$1,668,000
+88.5%
71,603
+53.9%
0.00%
+100.0%
Q3 2021$885,000
+124.1%
46,530
+137.7%
0.00%
Q2 2021$395,000
+11.9%
19,573
+1.7%
0.00%
Q1 2021$353,000
+29.3%
19,246
+41.8%
0.00%
Q4 2020$273,000
+16.2%
13,572
+8.4%
0.00%
Q3 2020$235,000
-20.9%
12,522
-5.2%
0.00%
Q2 2020$297,000
-62.8%
13,210
-75.4%
0.00%
-100.0%
Q1 2020$798,000
+5.7%
53,708
+37.2%
0.00%0.0%
Q4 2019$755,000
+98.7%
39,154
+104.4%
0.00%
Q3 2019$380,000
+280.0%
19,154
+241.4%
0.00%
Q2 2017$100,000
+44.9%
5,611
+17.7%
0.00%
Q1 2017$69,000
+176.0%
4,769
+206.3%
0.00%
Q2 2016$25,000
+56.2%
1,557
+14.9%
0.00%
Q1 2016$16,000
-11.1%
1,355
+8.5%
0.00%
Q4 2015$18,000
+28.6%
1,249
+5.7%
0.00%
Q3 2015$14,000
-26.3%
1,182
+9.7%
0.00%
Q2 2015$19,0001,0770.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders